CDKN1B Loss Fuels ER Therapy Resistance in Breast Cancer
In the evolving landscape of breast cancer treatment, hormone receptor-positive (HR+), HER2-negative breast cancer has long presented both opportunities and ...
In the evolving landscape of breast cancer treatment, hormone receptor-positive (HR+), HER2-negative breast cancer has long presented both opportunities and ...
Researchers at Ben-Gurion University of the Negev have made a groundbreaking discovery in the fight against triple-negative breast cancer (TNBC), ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine